SABCS 2014: Immunotherapy Shows Early Promise for Triple-negative Breast Cancer Patients

Print

After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope for women with a very challenging form of breast cancer—triple-negative breast …

Read More

Q&A With Lee Helman, MD, on New Cancer Targets and Therapeutics

Helman_Photo_external

The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses what to expect this year, and peers into the future of targeted cancer therapies and immunotherapy.

Read More